Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review)
- Authors:
- Hideya Onishi
- Katsuya Nakamura
- Kosuke Yanai
- Shuntaro Nagai
- Kazunori Nakayama
- Yasuhiro Oyama
- Akiko Fujimura
- Keigo Ozono
- Akio Yamasaki
-
Affiliations: Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812‑8582, Japan - Published online on: March 18, 2022 https://doi.org/10.3892/or.2022.8304
- Article Number: 93
This article is mentioned in:
Abstract
 |
 |
|
Balkwill FR, Capasso M and Hagemann T: The tumor microenvironment at a glance. J Cell Sci. 125:5591–5596. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rakhshandehroo T, Smith BR, Glockner HJ, Rashidian M and Pandit-Taskar N: Molecular immune targeted imaging of tumor microenvironment. Nanotheranostics. 6:286–305. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, Gong Z, Zhang S, Zhou J, Cao K, et al: Role of tumor microenvironment in tumorigenesis. J Cancer. 8:761–773. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H, Kai M, Odate S, Iwasaki H, Morifuji Y, Ogino T, Morisaki T, Nakashima Y and Katano M: Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer. Cancer Sci. 102:1144–1150. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H and Katano M: Hedgehog signaling pathway as a therapeutic target in various types of cancer. Cancer Sci. 102:1756–1760. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ingham PW and McMahon AP: Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Low JA and de Sauvage FJ: Clinical experience with hedgehog pathway inhibitors. J Clin Oncol. 28:5321–5326. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gailani MR and Bale AE: Developmental genes and cancer: Role of patched in basal cell carcinoma of the skin. J Natl Cancer Inst. 89:1103–1109. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Zurawel RH, Allen C, Chiappa S, Cato W, Biegel J, Cogen P, de Sauvage F and Raffel C: Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes Cancer. 27:44–51. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tostar U, Malm CJ, Meis-Kindblom JM, Kindblom LG, Toftgård R and Undén AB: Deregulation of the hedgehog signalling pathway: A possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol. 208:17–25. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kinzler KW, Bigner SH, Binger DD, Trent JM, Law ML, O'Brien SJ, Wong AJ and Vogelstein B: Identification of an amplified, highly expressed gene in a human glioma. Science. 236:70–73. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Thayer SP, di Magliano MP, Heiser PW, Nielson CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Castillo CF, Yajnik V, et al: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 425:851–856. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Qualtrough D, Buda A, Gaffield W, Williams AC and Paraskeva C: Hedgehog signalling in colorectal tumour cells: Induction of apoptosis with cyclopamine treatment. Int J Cancer. 110:831–837. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng WT, Xu K, Tian DY, Zhang ZG, Liu LJ and Chen Y: Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells. Int J Oncol. 34:829–836. 2009.PubMed/NCBI | |
|
Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA and Baylin SB: Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature. 422:313–317. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Horiuchi A, Kikuchi N, Osada R, Yoshida J, Shiozawa T and Konishi I: Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: It's inhibition leads to growth suppression and apoptosis. Cancer Sci. 98:68–76. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, Evers BM, Zhang H and Xie J: Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis. 26:1698–1705. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fan L, Pepicelli CV and Dibble CC: Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology. 145:3961–3970. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yamasaki A, Kameda C, Xu R, Tanaka H, Tasaka T, Chikazawa N, Suzuki H, Morisaki T, Kubo M, Onishi H, et al: Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh. Cancer Immunol Immunother. 59:675–686. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hockel S, Schlenger K, Vaupel P and Hockel M: Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer. Int J Oncol. 19:827–832. 2001.PubMed/NCBI | |
|
Lei J, Ma J, Ma Q, Li X, Liu H, Xu Q, Duan W, Sun Q, Xu J, Wu Z and Wu E: Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner. Mol Cancer. 12:662013. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H, Yamasaki A, Kawamoto M, Imaizumi A and Katano M: Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer. Cancer Lett. 371:143–150. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ables JL, Breunig JJ, Eisch AJ and Rakic P: Not(ch) just development: Notch signalling in the adult brain. Nat Rev Neurosci. 12:269–283. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H, Ichimiya S, Yanai K, Umebayashi M, Nakamura K, Yamasaki A, Imaizumi A, Nagai S, Murahashi M, Ogata H and Morisaki T: RBPJ and MAML3: Potential therapeutic targets for small cell lung cancer. Anticancer Res. 38:4543–4547. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tai H, Wu Z, Sun S, Zhang Z and Xu C: FGFRL1 promotes ovarian cancer progression by crosstalk with hedgehog signaling. J Immunol Res. 2018:74386082018. View Article : Google Scholar : PubMed/NCBI | |
|
Cao Y, Lin SH, Wang Y, Chin YE, Kang L and Mi J: Gultamic pyruvate transaminase GPT2 promotes tumorigenesis of breast cancer cells by activating sonic hedgehog signaling. Theranostics. 7:3021–3033. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu QH, Xiao Y, Li XQ, Fan L, Zhou CC, Cheng L, Jiang ZD and Wang GH: Resveratrol counteracts hypoxia-induced gastric cancer invasion and EMT through hedgehog pathway suppression. Anticancer Agents Med Chem. 20:1105–1114. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wei M, Ma R, Huang S, Liao Y, Ding Y, Li Z, Guo Q, Tan R, Zhang L and Zhao L: Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia xia. J Cell Physiol. 234:17392–17404. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sarighieh MA, Montazeri V, Shadboorestan A, Ghahremani MH and Ostad SN: The inhibitory effect on hypoxia inducer (Hifs) as a regulatory factor in the growth of tumor cells in breast cancer stem-like cells. Drug Res. 70:512–518. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cao L, Xiao X, Lei J, Duan W, Ma Q and Li W: Curcumin inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway. Oncol Rep. 35:3728–3734. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fu Z, Chen D, Cheng H and Wang F: Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia. Med Sci Monit. 21:319–325. 2015. | |
|
Meng X, Cai J, Liu J, Han B, Gao F, Gao W, Zhang Y, Zhang J, Zhao Z and Jiang C: Curcumin increases efficiency of γ-irradiation in gliomas by inhibiting Hedgehog signaling pathway. Cell Cycle. 16:1181–1192. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Hao M, Jin H, Yao Z, Lian N, Wu L, Shao J, Chen A and Zheng S: Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis. Br J Pharmacol. 175:409–423. 2017. View Article : Google Scholar | |
|
Zhang Q, Lou Y, Zhang J, Fu Q, Wei T, Sun X, Chen Q, Yang J, Bai X and Liang T: Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer. Mol Cancer. 16:1192017. View Article : Google Scholar : PubMed/NCBI | |
|
Criscimanna A, Duan LJ, Rhodes JA, Fendrich V, Wickline E, Hartman DJ, Monga SP, Lotze MT, Gittes GK, Fong GH and Esni F: PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis. Cancer Res. 73:4781–4790. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Moriyama H, Moriyama M, Ozawa T, Ttsuruta D, Iguchi T, Tamada S, Nakatani T, Nakagawa K and Hayakawa T: Notch signaling enhances stemness by regulating metabolic pathways through modifying p53, NF-κB, and HIF-1α. Stem Cells Dev. 27:935–947. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tian Q, Xue Y, Zheng W, Sun R, Ji W, Wang X and An R: Overexpression of hypoxia-inducible factor 1α induces migration and invasion through Notch signaling. Int J Oncol. 47:728–738. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kroon ME, Koolwijk P, van der Vecht B and van Hinsbergh VW: Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: Involvement of at least two signal transduction pathways. J Cell Sci. 114:825–833. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Le TBU, Vu TC, Ho RZW, Prawira A, Wang L, Goh BC and Huynh H: Bevacizumab augments the antitumor efficacy of infigratinib in hepatocellular carcinoma. Int J Mol Sci. 21:94052020. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta SC, Singh R, Pochampally R, Watabe K and Mo YY: Acidosis promotes invasiveness of vreast cancer cells through ROS-AKT-NF-kB pathway. Oncotarget. 5:12070–12082. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Prasad S, Gupta SC and Tyagi AK: Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer Lett. 387:95–105. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Eyrich NW, Potts CR, Robinson MH, Maximov V and Kenney AM: Reactive oxygen species signaling promotes hypoxia-inducible factor 1 α stabilization in sonic hedgehog-driven cerebellar progenitor cell proliferation. Mol Cell Biol. 39:e00268–18. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Tu K, Wang Y, Yao B, Li Q, Wang L, Dou C, Liu Q and Zheng X: Hypoxia accelerates aggressiveness of hepatocellular carcinoma cells involving oxidative stress, epithelial-mesenchymal transition and non-canonical hedgehog signaling. Cell Physiol Biochem. 44:1856–1868. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li W, Cao L, Chen Y, Lei J and Ma Q: Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the hedgehog signaling pathway. Oncol Rep. 35:1718–1726. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Morifuji Y, Onishi H, Iwasaki H, Imaizumi A, Nakano K, Tanaka M and Katano M: Reoxygenation from chronic hypoxia promotes metastatic processes in pancreatic cancer through the Hedgehog signaling. Cancer Sci. 105:324–333. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang RY, Qiao ZY, Liu HJ and Ma JW: Sonic hedgehog signaling regulates hypoxia/reoxygenation-induced H9C2 myocardial cell apoptosis. Exp Ther Med. 16:4193–4200. 2018.PubMed/NCBI | |
|
Fang Q, Zhang Y, Siang DS and Chen Y: Hydroxytyosol inhibits apoptosis in ischemia/reperfusion-induced acute kidney injury via activating sonic edgehog signaling pathway. Eur Rev Med Pharmacol Sci. 24:12380–12388. 2020.PubMed/NCBI | |
|
Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, Nedaeinia R, Haghjooy Javanmard S, Taherian M, Ahmadlou M, et al: The role of hypoxia in the tumor microenvironment and development of cancer stem cell: A novel approach to developing treatment. Cancer Cell Int. 21:622021. View Article : Google Scholar : PubMed/NCBI | |
|
Chapouly C, Guimbal S, Hollier PL and Renault MA: Role of hedgehog signaling in vasculature development, differentiation, and maintenance. Int J Mol Sci. 20:30762019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Wang Z, Kai J, Wang F, Jia Y, Wang S, Tan S, Shen X, Chen A, Shao J, et al: Curcumol attenuates liver sinusoidal endothelial cell angiogenesis via regulating Glis-PROX1-HIF-1 α in liver fibrosis. Cell Prolif. 53:e127622020. View Article : Google Scholar : PubMed/NCBI | |
|
Pinter M, Sieghart W, Schmid M, Dauser B, Prager G, Dienes HP, Trauner M and Peck-Radosavljevic M: Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma. United European Gastroenterol J. 1:265–275. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu XQ, Yang H, Lin MH, Shang HX, Peng J, Chen WJ, Chen XZ and Lin JM: Qingjie fuzheng granules regulates cancer cell proliferation, apoptosis and tumor angiogenesis in colorectal cancer xenograft mice via sonic hedgehog pathway. J Gastrointest Oncl. 11:1123–1134. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu ZX, Sun CC, Zhu YT, Wang Y, Wang T, Chi LS, Cai WH, Zheng JY, Zhou X, Cong WT, et al: Hedgehog signaling contributes to basic fibroblast growth factor-regulated fibroblast migration. Exp Cell Res. 355:83–94. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yao Q, Renault MA, Chapouly C, Vandierdonck S, Belloc I, Jaspard-Vinassa B, Daniel-Lamaziere JM, Laffargue M, Merched A, Desgranges C and Gadeau AP: Sonic hedgehog mediates a novel pathway of PDGF-BB-dependent vessel maturation. Blood. 123:2529–2437. 2014. View Article : Google Scholar | |
|
Hsieh A, Ellsworth R and Hsieh D: Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol. 226:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Maroufy V, Shah P, Asghari A, Deng N, Le RNU, Ramirez JC, Yaseen A, Zheng WJ, Umetami M and Wu H: Gene expression dynamic analysis reveals co-activation of sonic hedgehog and epidermal growth factor followed by dynamic silencing. Oncotarget. 11:1358–1372. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Bausch D, Fritz S, Bolm L, Wellner UF, Fernandez-Del-Castillo C, Warshaw AL, Thayer SP and Liss AS: Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer. Angiogenesis. 23:479–492. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Stewart GA, Hoyne GF, Ahmad SA, Jarman E, Wallace WAH, Harrison DJ, Haslett C, Lamb JR and Howie SEM: Expression of the developmental sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes. J Pathol. 199:488–495. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS, Witek RP, Alpini G, Venter J, Vandongen HM, et al: Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest. 118:3331–3342. 2008.PubMed/NCBI | |
|
Bailey JM, Swanson BJ, Hamada T, Eggers JP, Singh PK, Caffery TC, Ouellette MM and Hollingsworth MA: Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res. 14:5995–6004. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Spivak-Kroizman TR, Hostetter G, Posner R, Ariz M, Hu C, Demeure MJ, Hoff DV, Hingorani SR, Palculict TB, Izzo J, et al: Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res. 73:3235–3247. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Katagiri T, Kobayashi M, Yoshimura M, Morinibu A, Itasaka S, Hiraoka M and Harada H: HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of sonic hedgehog. Oncotarget. 9:10525–10535. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al: Inhibition of hedgehog signaling enhances delivery of chemotherapy in mouse model of pancreatic cancer. Science. 324:1457–1461. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Oyama Y, Onishi H, Koga S, Murahashi M, Ichimiya S, Nakayama K, Fujimura A, Kawamoto M, Imaizumi A, Umebayashi M, et al: Patched 1-interacting peptide represses fibrosis in pancreatic cancer to augment the effectiveness of immunotherapy. J Immunother. 43:121–133. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Steele NG, Biffi G, Kemp SB, Zhang Y, Drouillard D, Syu L, Hao Y, Oni TE, Brosnan E, Elyada E, et al: Inhibition of hedgehog signaling alters fibroblast composition in pancreatic cancer. Clin Cancer Res. 27:2023–2037. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xue J, Jsharma V, Hsieh MH, Chawla A, Murali R, Pandol SJ and Habtezion A: Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 6:71582015. View Article : Google Scholar : PubMed/NCBI | |
|
Ueshima E, Fujimori M, Kodama H, Felsen D, Chen J, Duack JC, Solomon SB, Coleman JA and Srimathveeravalli G: Macrophage-secreted TGF-β 1 contributes to fibroblast activation and ureteral stricture after ablation injury. Am J Physiol Renol Physiol. 317:F52–F64. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Javelaud D, Pierrat MJ and Mauviel A: Crosstalk between TGF-β and hedgehog signaling in cancer. FEBS Lett. 586:2016–2025. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dennler S, Andre J, Alexaki I, Li A, Magnaldo T, ten Dijke P, Wang XJ, Verrecchia F and Mauviel A: Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 67:6981–6986. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou X, Wang P, Ma Z, Li M, Teng X, Sun L, Wan G, Li Y, Guo L and Liu H: Novel interplay between sonic hedgehog and transforming growth factor-β1 in human nonalcoholic steatohepatitis. Appl Immunohistochem Mol Morphol. 28:154–160. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiayuan S, Junyan Y, Xiangzhen W, Zuping W, Jian N, Baowei H and Lifang J: Gant61 ameliorates CCl4-induced liver fibrosis by inhibition of hedgehog signaling activity. Toxicol Appl Pharmcol. 387:1148532020. View Article : Google Scholar : PubMed/NCBI | |
|
Noman MZ, Hasmim M, Messai Y, Terry S, Kieda C, Janji B and Chouaib S: Hypoxia: A key player in antitumor immune response. A review in the theme: Cellular responses to hypoxia. Am J Physiol Cell Physiol. 309:C569–C579. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H, Morisaki T, Kiyota A, Koya N, Tanaka H, Umebayashi M and Katano M: The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer. Cancer Immunol Immunother. 62:1029–1039. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Winning S and Fandrey J: Dendritic cells under hypoxia: How oxygen shortage affects the linkage between innate and adaptive immunity. J Immunol Res. 2016:51343292016. View Article : Google Scholar : PubMed/NCBI | |
|
Ogino T, Onishi H, Suzuki H, Morisaki T, Tanaka M and Katano M: Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions. Cancer Immunol Immunother. 61:409–424. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bosco MC, Pierobon D, Blengio F, Raggi F, Vanni C, Gattorno M, Eva A, Novelli F, Cappello P, Giovarelli M and Varesio L: Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: Identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood. 117:2625–2639. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pierobon D, Bosco MC, Blengio F, Raggi F, Eva A, Filippi M, Musso T, Novelli F, Cappello P, Varesio L and Giovarelli M: Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression. Eur J Immunol. 43:949–966. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu B and Wei C: Hypoxia induces overexpression of CCL28 to recruit Treg cells to enhance angiogenesis in lung adenocarcinoma. J Environ Pathol Toxicol Oncol. 40:65–74. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Westendorf AM, Skibbe K, Adamczyk A, Buer J, Geffers R, Hansen W, Pastille E and Jendrossek V: Hypoxia enhances immunosuppression by inhibiting CD4+ Effector T cell function and promoting treg activity. Cell Physiol Biochem. 41:1271–1284. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chiu DK, Xu IM, Lai RK, Tse AP, Wei LL, Koh HY, Li LL, Lee D, Lo RC, Wong CM, et al: Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26. Hepatology. 64:797–813. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Elia AR, Cappello P, Puppo M, Fraone T, Vanni C, Eva A, Musso T, Novelli F, Varesio L and Giovarelli M: Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J Leukoc Biol. 84:1472–1482. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L and Lewis CE: Hypoxia-induced gene expression in human macrophages: Implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol. 163:1233–1243. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Fingleton B, Vargo-Gogola T, Crawford HC and Matrisian LM: Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia. 3:459–468. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Sureshbabu SK, Chaukar D and Chiplunkar SV: Hypoxia regulates the differentiation and anti-tumor effector functions of γδT cells in oral cancer. Clin Exp Immunol. 201:40–57. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
de la Roche M, Ritter AT, Angus KL, Dinsmore C, Earnshaw CH, Reiter JF and Griffiths GM: Hedgehog signaling controls T cell killing at the immunological synapse. Science. 342:1247–1250. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Petty AJ, Li A, Wang X, Dai R, Heyman B, Hsu D, Huang X and Yang YJ: Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment. Clin Invest. 129:5151–5162. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yánez DC, Lau CI, Chawda MM, Ross S, Furmanski AL and Crompton TJ: Hedgehog signaling promotes T H 2 differentiation in naive human CD4 T cells. Allergy Clin Immunol. 144:1419–1423.e1. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Merchant JL and Ding L: Hedgehog signaling links chronic inflammation to gastric cancer precursor lesions. Cell Mol Gastroenterol Hepatol. 3:201–210. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H, Morisaki T, Kiyota A, Koya N, Tanaka H, Umebayashi M and Katano M: The Hedgehog inhibitor suppresses the function of monocyte-derived dendritic cells from patients with advanced cancer under hypoxia. Biochem Biophys Res Commun. 436:53–59. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ichimiya S, Fujimura A, Masuda M, Masuda S, Yasumatsu R, Umebayashi M, Tanaka H, Koya N, Nakagawa S, Yoshimura S, Onishi H, Nakamura M, Nakamura Y and Morisaki T: Contribution of pre-existing neoantigen-specific T cells to durable complete responses after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma. Immunol Invest. Sep 5–2021.(Epub ahead of print). doi: 10.1080/08820139.2021.1973491. View Article : Google Scholar : PubMed/NCBI | |
|
Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V and Chouaib S: PD-L1 is a novel direct target of HIF-1α, and its blockade under ypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 211:781–790. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cubillos-Zapata C, Avendaño-Ortiz J, Hernandez-Jimenez E, Toledano V, Casas-Martin J, Varela-Serrano A, Torres M, Almendros I, Casitas R, Fernández-Navarro I, et al: Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea. Eur Respir J. 50:17008332017. View Article : Google Scholar : PubMed/NCBI | |
|
Chakrabarti J, Holokai L, Syu L, Steele NG, Chang J, Wang J, Ahmed S, Dlugosz A and Zavros Y: Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer. Oncotarget. 9:37439–37457. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H, Fujimura A, Oyama Y, Yamasaki A, Imaizumi A, Kawamoto M, Katano M, Umebayashi M and Morisaki T: Hedgehog signaling regulates PDL-1 expression in cancer cells to induce anti-tumor activity by activated lymphocytes. Cell Immunol. 310:199–204. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu X and Lang J: Soluble PD-1 and PD-L1: Predictive and prognostic significance in cancer. Oncotarget. 8:97671–97682. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou K, Guo S, Li F, Sun Q and Liang G: Exosomal PD-L1: New insights into tumor immune escape mechanisms and therapeutic strategies. Front Cell Dev Biol. 8:5692192020. View Article : Google Scholar : PubMed/NCBI | |
|
Mühlbauer M, Fleck M, Schütz C, Weiss T, Froh M, Blank C, Schölmerich J and Hellerbrand C: PD-L1 is induced hepatocytes by viral infection and interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol. 45:520–528. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
D'Alessandris N, Palaia I, Pernazza A, Tomao F, Di Pinto A, Musacchio L, Leopizzi M, Di Maio V, Pecorella I, Benedetti Panici P, et al: PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer. Virchows Arch. 478:517–525. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Blank C and Mackensen A: Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: An update on implications for chronic infections and tumor evasion. Cancer Immunol Immunother. 56:739–745. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng X and Ju D: Hedgehog signaling pathway and autophagy in cancer. Int J Mol Sci. 19:22792018. View Article : Google Scholar : PubMed/NCBI | |
|
Yamasaki A, Yanai K and Onishi H: Hypoxia and pancreatic ductal adenocarcinoma. Cancer Lett. 484:9–15. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Milla LA, González-Ramírez CN and Palma V: Sonic hedgehog in cancer stem cells: A novel link with autophagy. Biol Res. 45:223–230. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Won H and Rubinsztein DC: Autophagy and mammalian development. Biochem Soc Trans. 41:1489–1494. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fan J, Ju D, Li Y, Wang S and Wang Z: A novel approach to overcome non-small-cell lung cancer: Co-inhibition of autophagy and Hedgehog pathway. Ann Oncol. 26:vii106–vii151. 2015. View Article : Google Scholar | |
|
Wang Y, Han C, Lu L, Magliato S and Wu T: Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells. Hepatology. 58:995–1010. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gagné-Sansfaçon J, Allaire JM, Jones C, Boudreau F and Perreault N: Loss of Sonic hedgehog leads to alterations in intestinal secretory cell maturation and autophagy. PLoS One. 9:e987512014. View Article : Google Scholar : PubMed/NCBI | |
|
Albini A, Cesana E and Noonan DM: Cancer stem cells and the tumor microenvironment: Soloists or choral singers. Curr Pharm Biotechnol. 12:171–181. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wu CP, Du HD, Gong HL, Li DW, Tao L, Tian J and Zhou L: Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction. Int J Oncol. 44:1652–1660. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sun X, Lv X, Yan Y, Zhao Y, Ma R, He M and Wei M: Hypoxia-mediated cancer stem cell resistance and targeted therapy. Biomed. Pharmacother. 130:1106232020. View Article : Google Scholar : PubMed/NCBI | |
|
Bhuria V, Xing J, Scholta T, Bui KC, Nguyen MLT, Malek NP, Bozko P and Plentz RR: Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma. Exp Cell Res. 385:1116712019. View Article : Google Scholar : PubMed/NCBI | |
|
Raghavan S, Snyder CS, Wang A, McLean K, Zamarin D, Buckanovich RJ and Mehta G: Carcinoma-associated mesenchymal stem cells promote chemoresistance in ovarian cancer stem cells via PDGF signaling. Cancers. 12:20632020. View Article : Google Scholar : PubMed/NCBI | |
|
Mondal S, Bhattacharya K and Mandal C: Nutritional stress reprograms dedifferention in glioblastoma multiforme driven by PTEN/Wnt/Hedgehog axis: A stochastic model of cancer stem cells. Cell Death Discov. 4:1102018. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka H, Nakamura M, Kameda C, Kubo M, Sato N, Kuroki S, Tanaka M and Katano M: The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells. Anticancer Res. 29:2147–2157. 2009.PubMed/NCBI | |
|
Bai JW, Wei M, Li JW and Zhang GJ: Notch signaling pathway and endocrine resistance in breast cancer. Front Pharmacol. 11:9242020. View Article : Google Scholar : PubMed/NCBI | |
|
Shang C, Lang B and Meng LR: Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells. Cancer Biol Ther. 19:113–119. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Castagnoli L, Tagliabue E and Pupa SM: Inhibition of the Wnt signalling pathway: An avenue to control breast cancer aggressiveness. Int J Mol Sci. 21:90692020. View Article : Google Scholar : PubMed/NCBI | |
|
Pandit H, Li Y, Li X, Zhang W, Li S and Martin RCG: Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma. BMC Cancer. 18:7832018. View Article : Google Scholar : PubMed/NCBI | |
|
Gargiulo G, Cesaroni M, Serresi M, de Vries N, Hulsman D, Bruggeman SW, Lancini C and van Lohuizen M: In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis. Cancer Cell. 23:660–676. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ader T, Norel R, Levoci L and Rogler LE: Transcriptional profiling implicates TGFbeta/BMP and Notch signaling pathways in ductular differentiation of fetal murine hepatoblasts. Mech Dev. 123:177–194. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Schartz NE, Chaput N, André F and Zitvogel L: From the antigen-presenting cell to the antigen-presenting vesicle: The exosomes. Curr Opin Mol Ther. 4:372–381. 2002.PubMed/NCBI | |
|
Mignot G, Roux S, Thery C, Segura E and Zitvogel L: Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med. 10:376–388. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Deep G and Panigrahi GK: Hypoxia-induced signaling promotes prostate cancer progression: Exosomes role as messenger of hypoxic response in tumor microenvironment. Crit Rev Oncog. 20:419–434. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gradilla AC, González E, Seijo I, Andrés G, Bischoff M, González-Mendez L, Sánchez V, Callejo A, Ibáñez C, Guerra M, et al: Exosomes as Hedgehog carriers in cytoneme-mediated transport and secretion. Nat Commun. 5:56492014. View Article : Google Scholar : PubMed/NCBI | |
|
Qi J, Zhou Y, Jiao Z, Wang X, Zhao Y and Li Y, Chen H, Yang L, Zhu H and Li Y: Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth through hedgehog signaling pathway. Cell Physiol Biochem. 42:2242–2254. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma A: Role of stem cell derived exosomes in tumor biology. Int J Cancer. 142:1086–1092. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bhat A, Sharma A and Bharti AC: Upstream Hedgehog signaling components are exported in exosomes of cervical cancer cell lines. Nanomedicine. 13:2127–2138. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao G, Li H, Guo Q, Zhou A, Wang X, Li P and Zhang S: Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma. Cancer Med. 9:2500–2513. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wada J, Onishi H, Suzuki H, Yamasaki A, Nagai S, Morisaki T and Katano M: Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions. Anticancer Res. 30:3747–3757. 2010.PubMed/NCBI | |
|
Matsumoto K, Morisaki T, Kuroki H, Kubo M, Onishi H, Nakamura K, Nakahara C, Kuga H, Baba E, Nakamura M, et al: Exosomes secreted from monocyte-derived dendritic cells support in vitro naïve CD4+ T cell survival through NF-(kappa)B activation. Cell Immunol. 231:20–29. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H, Kuroki H, Matsumoto K, Baba E, Sasaki N, Kuga H, Tanaka M, Katano M and Morisaki T: Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop. Cancer Immunol Immunother. 53:1093–1100. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Nakashima H, Nakamura M, Yamaguchi H, Yamanaka N, Akiyoshi T, Koga K, Yamaguchi K, Tsuneyoshi M, Tanaka M and Katano M: Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res. 66:7041–7049. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kasperczyk H, Baumann B, Debatin KM and Fulda S: Characterization of sonic hedgehog as a novel NF-kappaB target gene that promotes NF-kappaB-mediated apoptosis resistance and tumor growth in vivo. FASEB J. 23:21–33. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Cai K, Na W, Guo M, Xu R, Wang X, Qin Y, Wu Y, Jiang J and Huang H: Targeting the cross-talk between the hedgehog and NF-κB signaling pathways in multiple myeloma. Leuk Lymphoma. 60:772–781. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Nakayama K, Onishi H, Fujimura A, Imaizumi A, Kawamoto M, Oyama Y, Ichimiya S, Koga S, Fujimoto Y, Nakashima K and Nakamura M: NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytes. Cell Immunol. 358:1042372020. View Article : Google Scholar : PubMed/NCBI | |
|
Fosko SW, Chu MB, Armbrecht E, Galperin T, Potts GA, Mattox A, Kurta A, Polito K, Slutsky JB, Burkemper NM, et al: Efficacy, rate of tumor response, and safety of a short course (12–24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial. J Am Acad Dermatol. 82:946–954. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
De Jesus-Acosta A, Sugar EA, O'Dwyer PJ, Ramanathan RK, Von Hoff DD, Rasheed Z, Zheng L, Begum A, Anders R, Maitra A, et al: Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma. Br J Cancer. 122:498–505. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, Holcomb T, Pujara K, Stinson J, Callahan CA, Tang T, et al: Smoothened mutation confere resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science. 326:572–574. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Dijkgraaf GJ, Alicke B, Weinmann L, Januario T, West K, Modrusan Z, Burdick D, Goldsmith R, Robarge K, Sutherlin D, et al: Small molecule inhibition of GDC-0499 refractory smoothened mutants and downstream mechanisms of drug resistance. Cancer Res. 71:435–444. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Onishi H and Katano M: The Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer. World J Gastroenterol. 20:2335–2342. 2014. View Article : Google Scholar : PubMed/NCBI |
